Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Kidney & Blood Pressure Research|November 18, 2017
Inflammatory and Angiogenic Factors Linked to Longitudinal Microvascular Changes in Hemodialysis Patients Irrespective of Treatment Dose IntensityNicos Mitsides, Tom Cornelis, Natascha J H Broers, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: report from the Southwest Pediatric Nephrology Study GroupRonald J Hogg, Jeannette Lee, Nancy Nardelli, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 5, 2017
X-Linked Glomerulopathy Due to COL4A5 Founder VariantMoumita Barua, Rohan John, Lorenzo Stella, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 23, 2016
Genetic risk variants for membranous nephropathy: extension of and association with other chronic kidney disease aetiologiesPeggy Sekula, Yong Li, Horia C Stanescu, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 26, 2015
Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathyRonald J Hogg, R Curtis Bay, J Charles Jennette, et al.
Glomerular Diseases|April 24, 2023
A Genetic Risk Score Distinguishes Different Types of Autoantibody-Mediated Membranous NephropathySanjana Gupta, Mallory Lorraine Downie, Chris Cheshire, et al.
Nephron|March 7, 2021
Association of Obesity with Cardiovascular Risk Factors and Kidney Disease Outcomes in Primary Proteinuric GlomerulopathiesParas P Shah, Tammy M Brady, Kevin E C Meyers, et al.
American Journal of Physiology. Renal Physiology|November 17, 2017
Dapagliflozin in focal segmental glomerulosclerosis: a combined human-rodent pilot studyHarindra Rajasekeran, Heather N Reich, Michelle A Hladunewich, et al.
The Lancet. Diabetes & Endocrinology|June 20, 2020
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trialDavid Z I Cherney, Claire C J Dekkers, Sean J Barbour, et al.
Journal of the American Society of Nephrology : JASN|September 11, 2016
A Multicenter Study of the Predictive Value of Crescents in IgA NephropathyMark Haas, Jacobien C Verhave, Zhi-Hong Liu, et al.
Pageof 9